IMMUNO-ONCOLOGY
Last Updated: 13 Apr 2026
IMMUNO-ONCOLOGY is ACRA -registered entity that has been operating for 5 years 9 months in Singapore since its incorporation in 2020.
Officially, IMMUNO-ONCOLOGY is registered as Sole Proprietor with its address 10 UBI CRESCENT, #03-41, UBI TECHPARK, Singapore 408564.
Country of registration | Singapore |
Registration number | 53419013L |
Local SIC | |
Incorporation date | 17 Aug 2020 |
Company age | 5 years 9 months |
Official entity type | Sole Proprietor |
No. of officers | 1 |
Contact
Address:
10 UBI CRESCENT, #03-41, UBI TECHPARK, Singapore 408564
Access Key Decision Makers
This is the legal entity page of IMMUNO-ONCOLOGY. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
IMMUNO-ONCOLOGYView MoreSingapore
This is the legal entity page of IMMUNO-ONCOLOGY. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Revenue | < 1m |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of IMMUNO-ONCOLOGY?
- Where is IMMUNO-ONCOLOGY's headquarter?
- What is IMMUNO-ONCOLOGY's contact number?
- What IMMUNO-ONCOLOGY's spending power?
- Does IMMUNO-ONCOLOGY have a presence in the domain it operates in?